I like the good old Demand Push and Demand Pull marketing strategies, here adopted for today's news:
With 84 hospitals online and ready to go, if a successful treatment using OncoSil Medical Ltd's device were to be completed and results become available in Germany, it could significantly impact both a demand pull and demand push strategies for the OncoSilTM device:
Enhanced Demand Pull:
Increased Public Awareness and Interest: Successful treatment stories can significantly raise public awareness about the OncoSilTM device. This can lead to increased interest and demand from patients and healthcare providers.
Strengthening Consumer Confidence: Hearing about successful treatments can bolster confidence in the device's effectiveness, leading to more patients and doctors opting for it as a preferred treatment method.
Expanding Patient Demand: As more patients become aware of the successful treatments, they may actively seek out facilities that offer the OncoSilTM device, thus increasing the demand pull from consumers.
Amplified Demand Push:
Marketing Leverage: OncoSil Medical can utilize the publicity from the successful treatments in their marketing campaigns, using testimonials or case studies as a powerful tool to promote the device.
Increased Interest from Healthcare Providers: Hospitals and clinics that were previously hesitant may become more interested in acquiring the device, anticipating increased demand from patients.
Negotiation Leverage in Distribution:A positive treatment result can also be leveraged in negotiations with healthcare institutions and insurance companies, potentially making it easier to establish new distribution agreements or funding arrangements.
Broader Market Impact:
Wider Adoption in Healthcare Systems: Positive results can catalyze wider adoption of the OncoSilTM device within the healthcare system, possibly influencing policy changes or insurance coverage decisions.
International Interest: Successful treatment reports in one country can spark interest in other markets, potentially leading to international expansion opportunities.
Competitive Edge: Such publicity could give OncoSil Medical a competitive advantage, setting the OncoSilTM device apart from other cancer treatments available on the market.
Regulatory and Investment Implications:
Regulatory Support: Success stories can influence regulatory bodies, potentially leading to faster approvals or support for the device in new markets.
Attracting Investors: Positive media coverage and demonstrated success can attract more investors, boosting funding for further research, development, and expansion.
In summary, successful treatments in Germany using the OncoSilTM device could significantly amplify both demand pull and demand push factors, potentially accelerating the device's adoption, widening its market reach, and enhancing the overall profitability and growth prospects of OncoSil Medical Ltd.
Now add to this the PANCOSIL trial, with a newer, much easier application/delivery being explored.
....
- Forums
- ASX - By Stock
- Ann: 84 German hospitals can negotiate fee for Oncosil device
I like the good old Demand Push and Demand Pull marketing...
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $45.40M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $18.92K | 1.705M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 13619110 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 5063491 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 13469110 | 0.010 |
23 | 14339583 | 0.009 |
10 | 6887500 | 0.008 |
13 | 6339285 | 0.007 |
8 | 8595000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 4158618 | 8 |
0.013 | 11108832 | 8 |
0.014 | 6187166 | 8 |
0.015 | 8500000 | 3 |
0.016 | 4766668 | 3 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
OSL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online